Richie, Thomas L <br/><br/>
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  Nov 2012 
 - 1564-84 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.4161/hv.22129  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antigens, Protozoan--immunology<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--genetics<br/>Humans<br/>Malaria Vaccines--administration & dosage<br/>Male<br/>Middle Aged<br/>Plasmids--genetics<br/>Plasmodium falciparum--immunology<br/>Sporozoites--immunology<br/>Vaccines, DNA--adverse effects<br/>Young Adult